Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

UPGRADE

Advanced search

Watchlist | Portfolio | Dashboard

Horizon Therapeutics (HZNP)

N/A x N/A N/A x N/A

Post-market by (Cboe BZX)

116.30 +0.05 (+0.04%) 10/05/23 [NASDAQ]

N/A x N/A N/A x N/A

Post-market 116.30 unch (unch) -

Balance Sheet for Thu, Oct 5th, 2023

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2022	12-2021	12-2020	12-2019	12-2018
Assets
Current Assets
Cash & Cash Equivalents	2,357,588	1,584,156	2,083,479	1,080,039	962,117
Receivables	676,347	632,775	659,701	408,685	464,730
Inventories	169,559	225,730	75,283	53,802	50,751
TOTAL	$3,652,843	$2,799,767	$3,070,408	$1,686,103	$1,545,816

Non-Current Assets
PPE Net	340,509	292,298	189,037	30,159	20,101
Intangibles	3,675,315	4,026,827	2,196,631	2,116,297	2,363,938
Other Non-Current Assets	1,445,949	1,558,836	616,540	603,475	12,107
TOTAL	$5,461,773	$5,877,961	$3,002,208	$2,749,931	$2,396,146

Total Assets	$9,114,616	$8,677,728	$6,072,616	$4,436,034	$3,941,962

Liabilities
Current Liabilities
Short Term Debt	16,000	16,000	N/A	N/A	N/A
Accounts payable and accrued liabilities	155,800	30,125	37,710	21,514	30,284
Accrued Expenses	457,557	523,015	485,567	235,234	215,739
TOTAL	$949,137	$886,571	$875,740	$723,169	$708,687

Non-Current Liabilities
Long Term Debt	2,546,837	2,555,233	1,003,379	1,352,841	1,896,684
Deferred Revenues	N/A	N/A	N/A	N/A	4,901
aiOther Non-Current Liabilities	204,451	173,076	101,672	80,328	38,717
TOTAL	$3,093,305	$3,118,764	$1,171,525	$1,527,416	$2,043,169

Total Liabilities	$4,042,442	$4,005,335	$2,047,265	$2,250,585	$2,751,856

Shareholders' Equity
Shares Outstanding, K	228,448	229,167	224,048	189,942	169,619
Common Shares	23	23	22	19	17
Retained earnings	590,009	318,605	-215,886	-605,682	-1,178,769
Other shareholders' equity	12,943	-14,572	270	-1,490	-1,108
TOTAL	$5,072,174	$4,672,393	$4,025,351	$2,185,449	$1,190,106

Total Liabilities And Equity	$9,114,616	$8,677,728	$6,072,616	$4,436,034	$3,941,962